Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
Recruiting now NCT07447908
Run by University Health Network, Toronto · for 18 and older · All sexes
What this study is about
Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This multicentre study will validate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse outpatient HF population.
Who can join (things the study team will check)
✅ You may be able to join if…
- broad age range (> 18 years of age)
- NT-proBNP > 400 or 1000 if in AF
- Within 3 months post discharge from HF hospitalization/ HF ED visit/ HF rapid clinic visit with intensification of diuretic therapy
- NYHA functional class I-IV, heart failure with reduced and preserved ejection fraction
- Literacy in English
- Patient provided informed consent
🚫 You may not be able to join if…
- Unable to perform a CPET based on the standard protocol
- End stage renal disease requiring dialysis
- Living with LVAD
- MRP deems patient unfit for the study
- Post heart transplant
Where this trial is running
- Southlake Health, Newmarket, Ontario, Canada
- 200 Elizabeth Street, Toronto, Ontario, Canada
- Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
Who to contact
Ryan Li, MASc · 6479669330 · ryan.li@uhn.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07447908.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.